In a breakthrough for diagnostics, scientists have created an easy and effective test that identifies a heart failure ...

Moderna stock is trading sharply lower Monday afternoon as recent clinical setbacks overshadowed positive pipeline news.

The start of the trial marks an expansion of the firm's oncology pipeline, and the firm hopes mRNA-2808 will be the first of many T-cell engagers in its portfolio.

MAGA and MAHA are happily married in Florida, and nowhere more at home than in Sarasota County, where on a humid October night a crowd of several hundred gathered to ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the ...

All the victims of the ongoing opioid crisis do, too. And this is about more than addiction — as when rare but real cases of ...

It is evolutionarily certain that we will have more outbreaks, more pandemics, and frankly, they could be significantly worse than Covid,” says global health expert Seth Berkley.

I know why I’m here today, Mr. Secretary. An inquiry? Right. It’s a setup, but I got this place surrounded with nurses, and every last one knows how to apply a tongue depressor.

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

Moderna (MRNA) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

How deep will the anti-science MAHA invasion penetrate into Mississippi? Can beleaguered state health officer Dr. Daniel ...